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Abstract
Background The resection volume in relation to the breast volume is known to influence cosmetic outcome fol-
lowing breast-conserving therapy. It was hypothesised that three-dimensional ultrasonography (3-D US) could be
used to preoperatively assess breast and tumour volume and show high association with histopathological
measurements.
Methods Breast volume by the 3D-US was compared to the water displacement method (WDM), mastectomy
specimen weight, 3-D MRI and three different calculations for breast volume on mammography. Tumour volume by
the 3-D US was compared to the histopathological tumour volume and 3-D MRI. Relatedness was based on the
intraclass correlation coefficient (ICC) with corresponding 95% confidence interval (95% CI). Bland–Altman plots
were used to graphically display the agreement for the different assessment techniques. All measurements were
performed by one observer.
Results A total of 36 patients were included, 20 and 23 for the evaluation of breast and tumour volume (ductal
invasive carcinomas), respectively. 3-D US breast volume showed ‘excellent’ association with WDM, ICC 0.92 [95%
CI (0.80–0.97)]. 3-D US tumour volume showed a ‘excellent’ association with histopathological tumour volume, ICC
0.78 [95% CI (0.55–0.91)]. Bland–Altman plots showed an increased overestimation in lager tumour volumes
measured by 3-D MRI compared to histopathological volume.
Conclusions 3-D US showed a high association with gold standard WDM for the preoperative assessment of breast
volume and the histopathological measurement of tumour volume. 3-D US is an patient-friendly preoperative
available technique to calculate both breast volume and tumour volume. Volume measurements are promising in
outcome prediction of intended breast-conserving treatment.
Introduction
For early stage breast cancer, similar survival rates are
obtained when performing a mastectomy or breast-con-
serving therapy (i.e. partial removal of the breast followed
by whole breast irradiation; BCT) [1]. Considering the high
survival rates [2], (surgical) treatment decisions should
focus on health-related quality of life in addition to the
oncological outcomes. The type of surgery performed
influences health-related quality of life [3]. In order to
improve cosmetic outcome following BCT, multiple
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studies have focused on (preoperative) radiological imag-
ing to predict or improve the cosmetic outcome [4, 5].
One of these preoperative parameters is breast volume,
commonly assessed in the area of breast reconstructive
surgery [6]. Preoperative breast volume measurements
have been described using various three-dimensional (3-D)
techniques [6–10]. These techniques showed high concor-
dance for the preoperatively accessed breast volume in
comparison to the water displacement method (WDM or
Archimedes’ method). The WDM is considered the gold
standard for breast volume measurement, but is only
available following resection [9, 11].
Tumour volume studied as preoperative parameter has
been described to predict the expected resection volume
[11–13]. The resection volume in BCT is known to influ-
ence cosmetic outcome [13–16]. Tumour volume mea-
surement can be performed on both mammography and
breast ultrasonography [11–13]. No gold standard is
available for the preoperative assessment of tumour vol-
ume. In the postoperative setting the gold standard for
tumor volume is the volume as based on the freshly excised
tissue.
The tumour volume-to-breast volume ratio in combina-
tion with the quadrant of the breast where the tumour is
located is expected to be predictive for the cosmetic outcome
following BCT [5]. A precise measurement of both tumour
and breast volume is needed to enable this preoperative
prediction of the expected cosmetic outcome following
BCT. To access these volumes, a ultrasonography was
chosen since it has several advantages over the use of other
radiological modalities: it is widely available, affordable,
non-invasive and does not depend on ionising radiation as
compared to a mammography. It was hypothesised that 3-D
US could be used to measure breast and tumour volume and
furthermore shows a good associationwith histopathological
volumes. For this the ultrasound volumewas compared to the
WDM, histopathological mastectomy specimen weight, 3-D
MRI and mammography for breast volume and the
histopathological tumour volume, 3-D MRI and mammog-
raphy for tumour volume.
Materials and methods
This prospective study was approved by the Ethics Com-
mittee of the Erasmus MC. Patients operated between
March 2015 and December 2015 with a preoperative breast
MRI were included prior to surgery after written informed
consent was obtained. Since the study is considered an
feasibility study, no power analysis was performed.
Patients undergoing a mastectomy were eligible for breast
and tumour volume measurement. Patients undergoing a
prophylactic mastectomy were eligible for breast volume
measurement where those scheduled for BCT were eligible
for tumour volume measurement. All measurements were
performed by one observer.
Histopathological evaluation
Breast volume (N = 20) was measured on freshly excised
breast specimen using two techniques. Primarily, the water
displacement method (WDM) was used intraoperatively.
WDM is based on Archimedes’ theory and considered gold
standard [9, 11]. The mastectomy specimen was submerged
into a graduated cup partly filled with water. The displaced
water is than equal to the volume of the specimen. Second
the breast volume was calculated by multiplying the
specimen weight (gram) by the molecular weight, esti-
mated to be 0.958 g/cm3 [17]. This molecular weight
resembles the situation where the breast consists of 50%
fatty tissue and 50% fibro-glandular tissue.
Tumour volume (N = 23) was calculated assuming the
tumour to resemble an obloid spheroid (Fig. 1) [18]. Three
diameters of the carcinoma were obtained on the fresh
tissue specimen. If ductal carcinoma in situ (DCIS) was
present in the direct surrounding of the invasive compo-
nent, the longest diameter of this area was additionally
obtained. If a DCIS component was larger than 1.5 cm,
patients were categorised as ‘DCIS[ 1.5’. If a DCIS
component was smaller than 1.5 cm, patients were cate-
gorised as ‘DCIS\ 1.5’.
Preoperative imaging
Automated breast volume scanner (ABVS) (3-D US)
3-D US was performed using the Siemens Automated
Breast Volume Scanner (ABVS—ACUSON S2000TM
ABVS, Siemens Medical Solutions, Inc, Mountain View,
CA) [19]. The ABVS uses a linear transducer (17 cm) that
automatically scans the breast in 60 s. Total breast volume
was captured conducting three or five scans per breast
based on size of the breast (i.e. anterior–posterior, lateral
Fig. 1 Mammographic determination of tumour volume [18]
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and medial or anterior–posterior, upper-lateral, lower-lat-
eral, upper-medial and lower-medial). Ultrasonography
data were analysed using a virtual reality desktop system
developed by the department of Bioinformatics, Erasmus
MC, running the V-Scope software [20]. This software
enables volume measurements in a 3-D-plane by display-
ing the ABVS data on a virtual reality desktop system.
Data can then be manipulated with a 3-D-mouse and
wireless pointer. Calculations were based on differences
found in grey levels (echogenicity).
3-D breast MRI
Contrast enhanced-MRI data were analysed using the
V-Scope software in a four-walled CAVE Automatic Vir-
tual Environment I-Space system (Barco NV, Kortrijk,
Belgium). Here eight projectors create an interactive
hologram enabling manipulations with a wireless joystick.
Volumes were calculated based on differences in grey
levels representing different anatomical structures [21].
Mammography
Breast volume by mammography was measured based on
two formulas (see below). The first equation considers the
breast as a half-elliptic shape and accounts for the com-
pression force of the breast (Fig. 2a) [22]. The height (h)
and width (w) of the base of the breast were measured in a
medio-lateral-oblique view of the mammography. The
compression during the mammography was encountered in
the formula as ‘c’, which is expressed as the compression
in millimetres. The second measurement considers the
breast to best resemble a circular cone (Fig. 2b). The height
of the breast was expressed as ‘h’, and the width of the base
of the breast was expressed as ‘r’. In literature, available
different mammography views (i.e. cranio-caudal [15],
medio-lateral-oblique [23] or a combination of the two
[17]) are used for this second formula.
Breast volume half - elliptic shape ¼ p=4ð Þ hwc ð1Þ
Breast volume circular cone ¼ 1=3 pr2h ð2Þ
Tumour volume was measured considering the tumour
as an obloid spheroid equal to the tumour volume measured
during histopathological evaluation (Fig. 1) [18].
Data analysis
Data were analysed using IBM SPSS Statistics (21.0.0.1).
The median breast volume (cm3) and tumour volume (cm3)
with corresponding interquartile ranges were obtained per
modality. The single measure intraclass correlation coef-
ficient (ICC) with 95% confidence interval was used to
calculate the measure of reliability between the different
measurement techniques. For the interpretation of the
reliability, an ICC of\0.40 ‘Poor’, an ICC of 0.40–0.59 as
‘Fair’, an ICC of 0.60–0.74 as ‘Good’, an ICC of 0.74–1.00
as ‘Excellent’ [24]. All breast volume measurement was
compared to the WDM (gold standard). For tumour vol-
ume, a comparison was made to the volume measured on
freshly excised specimens. Bland–Altman plots were used
to visualise the accuracy for the preoperative breast volume
and tumour volume techniques compared to histopatho-
logical volume. The y-axis displays the absolute difference
between the two techniques (technique A – B), and the x-
axis displays the averaged volume of the two techniques
(technique (A ? B)/2). The corresponding limits of
agreement are graphically displayed to evaluate the dif-
ference in relation to the breast or tumour volume (i.e. the
upper and lower limit representing the boundaries of the
95% confidence interval).
Fig. 2 Mammographic
determination of breast volume.
a Breast volume as a elliptic
shape [22]. b Breast volume as a
circular cone [15, 17, 23]
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Results
A total of 20 and 23 specimens were used for the evalua-
tion of breast and tumour volume, respectively. Median
breast volume measured by WDM (gold standard) was
462 cm3 [interquartile range, IQR (300–850)] (Table 1).
All carcinomas available in the study were ductal carci-
nomas. Median tumour volume measured by histopatho-
logical evaluation was 1.33 cm3 [IQR (0.42–3.28)]
(Table 1).
Breast volume
3-D US showed an ‘excellent’ association with the WDM,
intraclass correlation coefficient (ICC) 0.92 [95% CI
(0.80–0.97)] (Table 2). 3-D MRI, mammographic breast
volume by Kalbhen, Katariya, Fung and Cochrane addi-
tionally showed an ‘excellent’ association with the WDM,
ICC 0.95 [95% CI (0.87–0.98)], 0.91 [95% CI
(0.77–0.97)], 0.90 [95% CI (0.75–0.96)] and 0.81 [95% CI
(0.55–0.93)], respectively (Table 2). Agreements for
WDM with 3-D US, 3-D MRI and mammographic breast
volume by Kalbhen (MxKalbhen) are graphically displayed
by Bland–Altman plots (Fig. 3). It is shown that the dif-
ferences for the two techniques fall mainly between the
limits of agreement. For the 3-D MRI, a substantial
increase in the overestimation is seen with an increasing
breast volume (Fig. 3b).
Tumour volume
3-D US showed ‘excellent’ association with histopatho-
logical tumour volume, ICC 0.78 [95% CI (0.55–0.91)]
(Table 3). 3-D MRI showed a ‘good’ association with
histopathological tumour volume, ICC of 0.73 [95% CI
Table 1 Median volume (cm3) (interquartile range)
Breast volume (n = 20) (cm3)
Water displacement method (WDM) 462 (300–850)
Breast volume by molecular weight 432 (350–676)
3-D US 427 (315–779)
3-D MRI 550 (436–1175)
MxKalbhen 575 (438–681)
MxCochrane 809 (706–1019)
MxFung 766 (614–1000)
MxKatariya 742 (559–1000)
Tumour volume (n = 23) (cm3)
Histopathological tumour volume 1.33 (0.42–3.28)
3-D US 1.15 (0.43–1.79)
3-D MRI 2.24 (0.97–3.97)
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(0.44–0.88)] (Table 3). Mammographic assessment of
tumour volume was discarded since only in 14/23 (60.8%)
tumour volume could be assessed. Agreements for
histopathological tumour volume and 3-D US and 3-D MRI
are graphically displayed by Bland–Altman plots (Fig. 4).
Differences between the techniques fall within the limits of
agreement except for one measurement.
Ten patients (43.5%) had more than 1.5 cm diameter of
ductal carcinoma in situ (DCIS) and were considered as
‘DCIS[ 1.5’. For the ‘DCIS[ 1.5’ group ‘Poor’ relia-
bility scores were found for both 3-D US and 3-D MRI
with histopathological tumour volume, ICC, respectively,
0.01 [95% CI (-0.64 to 0.63)] and 0.04 [95% CI (-0.61 to
0.66)]. For the ‘DCIS\ 1.5’ group the association for 3-D
US and 3-D MRI with histopathological tumour volume
was ‘Excellent, ICC 0.86 [95% CI (0.57–0.96)] and ICC
0.88 [95% CI (0.63–0.96)], respectively.
Fig. 3 Bland–Altman plots for breast volume with the mean
difference (solid line) and limits of agreement (dotted line).
BV = breast volume, WDM = water displacement method,
US = ultrasound, Mx = mammography. a Mean difference
(WDM - 3-D US) as a function of the volume ((WDM ? 3-D
US)/2). b Mean difference (WDM - 3-D MRI) as a function of the
volume (WDM ? 3-D MRI). c Mean difference (WDM - MxKalb-
hen) as a function of the volume ((WDM ? MxKalbhen)/2)
Table 3 Intraclass correlation coefficienta (95% confidence interval)
for tumour volume measurements
Histopathological tumour volume 3-D US
3-D US 0.78 (0.55–0.91)
3-D MRI 0.73 (0.44–0.88) 0.94 (0.87–0.98)
TV tumour volume, US ultrasound
aICC of\ 0.40 ‘Poor’, an ICC of 0.40–0.59 as ‘Fair’, an ICC of
0.60–0.74 as ‘Good’, an ICC of 0.74–1.00 as ‘Excellent’ [24]
Fig. 4 Bland–Altman plots tumour volume with the mean difference
(solid line) and limits of agreement (dotted line). TV = tumour
volume, US = ultrasound. a Mean difference (PA - 3-D US) as a
function of the volume ((PA ? 3-D US)/2). b Mean difference
(PA - 3-D MRI) as a function of the volume ((PA ? 3-D MRI)/2)
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Discussion
Breast volume measurement by 3-D US as well as by
Kalbhen mammography shows an ‘excellent’ association
with gold standard water displacement method (WDM)
with ICC of 0.92 and 0.95, respectively. Tumour volume
measurement by 3-D US shows ‘excellent’ association with
histopathological tumour volume (ICC 0.78). The impor-
tance of breast volume and tumour volume measurements
preoperatively could be the cosmetic outcome prediction of
breast-conserving treatment. In literature, volume mea-
surements indeed enabled preoperative evaluation of the
expected resection volume in ratio with the breast volume
and thus a possible prediction of the expected cosmetic
outcome [5, 13, 14]. Currently 3-D US is being used in a
randomised controlled trial with the aim to preoperatively
predict whether BCT will generate a good cosmetic result
based on the tumour volume-to-breast volume ratio (NTR
4997).
A strength of the current study is that volumes were
evaluated by all mentioned measurement techniques per
patient: WDM and histopathological tumour volume if
applicable, 3-D US, 3-D MRI, and tumour volume by
mammographic formulas. To our knowledge, this is the
first study to report on breast volume assessment using 3-D
ABVS images. The availability of both breast volume and
tumour volume measured on freshly excised specimens
enabled an accurate comparison.
A limitation of the current study is that only ductal
carcinomas of the breast were available within the cohort.
It is therefore uncertain if results for tumour volume are
generalisable for other histological subtypes. Mammogra-
phy was considered unsuitable as a preoperative technique
to access tumour volume at the time of evaluation; no
tomography was available that could have possibly
increased tumour visibility in dense breast tissue. The
interpretation of the intraclass correlation coefficient (ICC)
to rate the level of reliability varies in literature
[11, 24, 25], making an unambiguous interpretation more
difficult. Martins [25] suggested much higher cut-off val-
ues when interpreting the reliability of ultrasound in foetal
measurements. Clauser et al. [11], however, used compa-
rable cut-off values for their interpretation of the reliability
of a 3-D US in breast cancer patients without referring to
their guide for interpretation. Although different cut-off
values are used, it should be taken into account that the
ICC is dependent on the total variance found in the samples
and should therefore be interpreted in the clinical setting
used.
The precise differentiation between the invasive com-
ponent and DCIS on histopathology enabled judgment on
the performance of both 3-D US and 3-D MRI since DCIS
is often not visible on ultrasonography as compared to the
contrast enhanced 3-D MRI images [26, 27]. To evaluate
the accuracy for both 3-D US and 3-D MRI, a differenti-
ation was made in the histopathological evaluation for the
invasive component (visible on ultrasonography) and for
the amount of DCIS. A subgroup analysis, evaluating only
patients without DCIS, was not performed due to a limited
patient number (n = 7). It is however expected to show an
‘excellent’ association with tumor volume as seen in
patients\1.5 cm DCIS. It is uncertain if the chosen dif-
ferentiation between\1.5 cm DCIS and[1.5 cm DCIS is
an accurate cut-off value which forms a limitation of the
study. The preoperative calculation of the tumour volume
in the presence of a known or expected large diameter of
DCIS should be performed with caution.
Overall 3-D US enables an accurate preoperative,
patient-friendly breast volume assessment without the use
of ionising radiation as in mammography. As confirmed in
our cohort, mammographic breast volume shows high
relatedness with both the WDM [7] and breast volume by
mastectomy specimen weight technique [17, 22]. As a
preoperative technique, 3D-US is expected to be a suit-
able and patient-friendly alternative with equal high cor-
relation to the WDM technique as obtained by
mammography.
Tumour volume measured by ultrasound has been
studied to preoperatively estimate the expected resection
volume with high concordance to the histopathological
volume [12, 13]. Clauser et al. [11] showed high concor-
dance comparing tumour volume by MRI with tumour
volume by hand-held ultrasonography and histopathologi-
cal tumour volume. Various studies, however, showed an
overestimation of the tumour volume by MRI [28–30].
This overestimation was confirmed within our cohort as
presented by the Bland–Altman plot (Fig. 4) and can pos-
sibly be explained by the contrast enhancement images
which colour the surrounding of the tumour or the presence
of DCIS (as shown by the overall larger tumour volumes
measured by MRI). As shown in the Bland–Altman anal-
ysis, 3-D US is more accurate in predicting histopatho-
logical tumour volume than 3-D MRI when smaller lesions
are evaluated. As expected, 3-D MRI showed better relat-
edness to histopathological tumour volume in the presence
of DCIS if\1.5 cm in the direct surrounding of the tumour
(ICC 3-D MRI 0.88 compared to ICC 3-D US 0.86 both in
relation to histopathological volume).
In conclusion, breast volume can accurately be assessed
by mammography based on Kalbhen’s technique or by 3D-
US which forms a more patient-friendly alternative.
Tumour volume (with limited DCIS) measurement by 3D-
US and 3D-MRI was comparably adequate with ‘excellent’
to ‘good’ relatedness for histopathology. Future research
should further evaluate the use of preoperative volume
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measurements as a tool to predict cosmetic outcome of
intended breast-conserving treatment. Currently a ran-
domised controlled trial is ongoing evaluating the effec-
tiveness of a preoperative prediction of the tumour volume-
to-breast volume ratio to improve cosmetic outcome in
breast cancer patients opting for BCT (NTR 4997).
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